Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies

Drug Discovery Today(2023)10.1016/j.drudis.2023.103487Source: DataRank Database

Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies is a research paper published in Drug Discovery Today (2023). On theSindex it has a DataRank of 0. It has been cited 82 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access82 citations

Download PDF

Cite:

Linked data & code

pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: greenTopics (13)IDs (PubMed, PMC)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Ta-Jung Hung,Jessica S. Fortin ORCID,Kendall B. E. Moore ORCID

Live enrichment

PubMed:36634842 PMC:PMC9975055

NIA NIH HHS

Grant: K08 AG071985

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9975055/pdf/nihms-1863653.pdf

publisherhttps://api.elsevier.com/content/article/PII:S135964462300003X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S135964462300003X?httpAccept=text/plain

MeSH Terms

Neurofibrillary TanglesHumansAlzheimer DiseaseTauopathiestau ProteinsPhosphorylationDrug Discovery

Keywords

AmyloidTherapyTauDementiahyperphosphorylationAlzheimer’s

Related Papers (10)

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

N/A

2.9DataRank · unranked

Molecular Psychiatry(2020)

co-cited

10.1038/s41380-020-0806-5

Comprehensive plasma proteomic profiling reveals biomarkers for active tuberculosis

N/A

0.628DataRank · unranked

JCI Insight(2020)

co-cited

10.1172/jci.insight.137427

Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study

N/A

0.961DataRank · unranked

The Lancet Neurology(2021)

co-cited

10.1016/s1474-4422(21)00214-3

Alzheimer's disease associated with Down syndrome: a genetic form of dementia

N/A

0.885DataRank · unranked

The Lancet Neurology(2021)

co-cited

10.1016/s1474-4422(21)00245-3

Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges

N/A

0.596DataRank · unranked

Frontiers in Endocrinology(2021)

co-cited

10.3389/fendo.2021.671946

Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring

Nature Medicine(2022)

co-cited

10.1038/s41591-022-02074-w

Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer’s disease

GeroScience(2022)

co-cited

10.1007/s11357-022-00708-y

Plasma p‐tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease

Alzheimer s & Dementia(2022)

co-cited

10.1002/alz.12906

SOD1 mediates lysosome-to-mitochondria communication and its dysregulation by amyloid-β oligomers

Neurobiology of Disease(2022)

co-cited

10.1016/j.nbd.2022.105737

DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients

Biomedicines(2022)

co-cited

10.3390/biomedicines10061380

Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies

FAIR Checklist

Authors (3)

Funding (1 grants)

Open Access

Topics

Annotations (Europe PMC)

Related Papers (10)